These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11926576)

  • 21. [Treatment of Helicobacter pylori infections].
    Hentschel E
    Acta Med Austriaca; 2000; 27(4):104-7. PubMed ID: 10989677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori.
    Thong-Ngam D; Tangkijvanich P; Treeprasertsuk S; Wisedopas N; Kullavanijaya P
    J Med Assoc Thai; 2002 Oct; 85(10):1054-9. PubMed ID: 12501895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Key points from the revised Maastricht Consensus Report: the impact on general practice.
    Bazzoli F
    Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S3-7. PubMed ID: 11686230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
    Lamouliatte H; Samoyeau R; De Mascarel A; Megraud F
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1523-30. PubMed ID: 10571611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
    Buzás GM; Józan J
    Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
    Hung WK; Wong WM; Wong GS; Yip AW; Szeto ML; Lai KC; Hu WH; Chan CK; Xia HH; Yuen MF; Fung FM; Tong TS; Ho VY; Lam SK; Wong BC
    Aliment Pharmacol Ther; 2002 Dec; 16(12):2067-72. PubMed ID: 12452939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori eradication therapy.
    Suzuki H; Nishizawa T; Hibi T
    Future Microbiol; 2010 Apr; 5(4):639-48. PubMed ID: 20353303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori and non-malignant diseases.
    Rokkas T; Simsek I; Ladas S
    Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Helicobacter pylori: reasons for eradication].
    Schuster M
    Praxis (Bern 1994); 2004 Dec; 93(51-52):2135-41. PubMed ID: 15672764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
    Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
    Köksal AS; Parlak E; Filik L; Yolcu OF; Odemiş B; Ulker A; Saşmaz N; Ozden A; Sahin B
    J Gastroenterol Hepatol; 2005 Apr; 20(4):637-42. PubMed ID: 15836716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Report from an international consensus conference in Maastricht. Management and treatment of Helicobacter pylori infection].
    Sjölund K; Ljungh A
    Lakartidningen; 2001 Mar; 98(11):1235-8. PubMed ID: 11293128
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of Helicobacter pylori eradication on patients with functional dyspepsia].
    de Artaza Varasa T; Valle Muñoz J; Pérez-Grueso MJ; García Vela A; Martín Escobedo R; Rodríguez Merlo R; Cuena Boy R; Carrobles Jiménez JM
    Rev Esp Enferm Dig; 2008 Sep; 100(9):532-9. PubMed ID: 19025303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in israel: are we missing the malignant potential of Helicobacter pylori?
    Shirin H; Birkenfeld S; Shevah O; Levine A; Epstein J; Boaz M; Niv Y; Avni Y
    J Clin Gastroenterol; 2004 Apr; 38(4):322-5. PubMed ID: 15087690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant increase in eradication rates of Helicobacter pylori infection with two consecutive dual therapies (omeprazole and amoxycillin or omeprazole and clarithromycin). A randomized study in 450 Spanish patients.
    Moreno JA; Pajares JM; Santander C; Carpintero P; Hermida C; Lara S; García Grávalos R
    J Gastroenterol; 1996 Nov; 31 Suppl 9():48-52. PubMed ID: 8959519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection.
    Cammarota G; Cannizzaro O; Ojetti V; Cianci R; Pastorelli A; Armuzzi A; Gentiloni N; Gasbarrini A; Pirozzi G; Gasbarrini G
    Aliment Pharmacol Ther; 2000 Jan; 14(1):73-7. PubMed ID: 10632648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.
    Gut; 1997 Jul; 41(1):8-13. PubMed ID: 9274464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of two-week therapy with ranitidine bismuth citrate, amoxicillin and clarithromycin on Helicobacter pylori eradication in clarithromycinresistant and- sensitive cases.
    Aydin A; Onder GF; Akarca US; Tekin F; Tunçyürek M; Musoğlu A
    Turk J Gastroenterol; 2005 Dec; 16(4):203-6. PubMed ID: 16547848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
    Talley NJ; Vakil N; Ballard ED; Fennerty MB
    N Engl J Med; 1999 Oct; 341(15):1106-11. PubMed ID: 10511608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.